PHR Q1 Earnings Call: Revenue Misses, Profitability Surges Amid Product ExpansionHealthcare technology company Phreesia (
NYSE:PHR) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 14.5% year on year to $115.9 million. Its GAAP loss of $0.07 per share increased from -$0.35 in the same quarter last year.
Phreesia (NYSE:PHR) Surprises With Q1 SalesHealthcare technology company Phreesia (
NYSE:PHR) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 14.5% year on year to $115.9 million. The company expects the full year’s revenue to be around $477 million, close to analysts’ estimates. Its GAAP loss of $0.07 per share was 35.6% above analysts’ consensus estimates.
Phreesia Announces First Quarter Fiscal 2026 Results
Phreesia, Inc. (
NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2025.
Phreesia (PHR) Reports Q1: Everything You Need To Know Ahead Of EarningsHealthcare technology company Phreesia (
NYSE:PHR) will be reporting results tomorrow after market hours. Here’s what investors should know.
3 of Wall Street’s Favorite Stocks Skating on Thin IceWall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Phreesia Updates May 28, 2025, Earnings Release Information for Fiscal First Quarter 2026 Results
Phreesia, Inc. (
NYSE: PHR) (“Phreesia”) today announced that it will now release its fiscal first quarter 2026 financial results prior to the open of market trading on Wednesday, May 28, 2025. Phreesia previously announced that it would release the results after the close of market trading on the same day. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal first quarter results starting at 8:30AM Eastern Time on the same day.
1 Cash-Heavy Stock with Impressive Fundamentals and 2 to IgnoreCompanies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments.
Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.
Phreesia Sets Release Date for Fiscal First Quarter 2026 Results
Phreesia, Inc. (
NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal first quarter 2026 financial results after the close of market trading on Wednesday, May 28, 2025. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal first quarter results starting at 5PM Eastern Time on the same day.
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers StocksThe end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Evolent Health (
NYSE:EVH) and the rest of the healthcare technology for providers stocks fared in Q4.
Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers StocksQuarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Omnicell (
NASDAQ:OMCL) and the best and worst performers in the healthcare technology for providers industry.
Q4 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers StocksLooking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Premier (
NASDAQ:PINC) and its peers.
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs PeersLet’s dig into the relative performance of Hims & Hers Health (
NYSE:HIMS) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.
Q4 Rundown: Astrana Health (NASDAQ:ASTH) Vs Other Healthcare Technology for Providers StocksWrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (
NASDAQ:ASTH) and its peers.
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology StocksLet’s dig into the relative performance of Tandem Diabetes (
NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.
Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To KnowA number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%, while the baseline 10% tariffs remained in place for most countries. This added layer of uncertainty reminded investors that the global trade environment remained volatile, limiting the potential for sustained market gains.
1 Healthcare Stock with Exciting Potential and 2 to IgnoreHealthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns -
over the past six months, healthcare stocks have collectively shed 9.5%. This drop was worse than the S&P 500’s 2.3% loss.
1 Small-Cap Stock with Solid Fundamentals and 2 to IgnoreMany small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR)Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Phreesia (
NYSE:PHR) and its peers.
Phreesia Named to G2’s List of 2025 Best Healthcare Software Products
Phreesia, a leader in patient intake, outreach and activation, has been named to G2’s 2025 Best Software Awards in the Best Healthcare Software Products category. As the world’s largest and most trusted software marketplace, G2 reaches 100 million buyers annually. Its annual Best Software Awards rank the world’s best software companies and products based on authentic, timely reviews from real users. Phreesia’s digital solutions enhance the patient experience and drive efficiency for healthcare providers.
Phreesia (NYSE:PHR) Posts Better-Than-Expected Sales In Q4 But Stock DropsHealthcare technology company Phreesia (
NYSE:PHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 15.4% year on year to $109.7 million. The company expects the full year’s revenue to be around $477 million, close to analysts’ estimates. Its GAAP loss of $0.11 per share was 35% above analysts’ consensus estimates.
Phreesia Announces Fourth Quarter Fiscal 2025 Results
Phreesia, Inc. (
NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2025.
